학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 22건 | 목록 1~10
Academic Journal
Venken T; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium.; Miller IS; Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.; Arijs I; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium.; Thomas V; Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.; Barat A; Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.; Betge J; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, German Cancer Research Center (DKFZ), Heidelberg, Germany.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Zhan T; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Gaiser T; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Ebert MP; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.; Molecular Medicine Partnership Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; O'Farrell AC; Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.; Prehn J; Centre for Systems Medicine, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.; Klinger R; UCD Conway Institute of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.; O'Connor DP; Department of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.; Moulton B; Cancer Trials Ireland, Dublin, Ireland.; Murphy V; Cancer Trials Ireland, Dublin, Ireland.; Serna G; Val d'Hebron Institute of Oncology, Barcelona, Spain.; Nuciforo PG; Val d'Hebron Institute of Oncology, Barcelona, Spain.; McDermott R; Cancer Trials Ireland, Dublin, Ireland.; Department of Medical Oncology, Tallaght University Hospital, Dublin, Ireland.; Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland.; Bird B; Bon Secours Cork Cancer Centre, Bon Secours Hospital Cork, Cork, Ireland.; Leonard G; University Hospital Galway, Newcastle Road, Galway, Ireland.; Grogan L; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Horgan A; Department of Medical Oncology, South East Cancer Center, University Hospital Waterford, Waterford, Ireland.; Schulte N; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Moehler M; Department of Medicine, Johannes-Gutenberg University Clinic, Mainz, Germany.; Lambrechts D; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium. diether.lambrechts@kuleuven.be.; VIB Center for Cancer Biology, Leuven, Belgium. diether.lambrechts@kuleuven.be.; Byrne AT; Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland. annettebyrne@rcsi.ie.
Publisher: Springer Nature in partnership with the Center of Excellence in Genomic Medicine Research at King Abdulaziz University Country of Publication: England NLM ID: 101685193 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-7944 (Electronic) Linking ISSN: 20567944 NLM ISO Abbreviation: NPJ Genom Med Subsets: PubMed not MEDLINE
Academic Journal
Serra-Camprubí Q; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Verdaguer H; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Oliveros W; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain.; Lupión-Garcia N; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Llop-Guevara A; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Molina C; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Vila-Casadesús M; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Turpin A; Université de Lille, CNRS INSERM UMR9020-U1277, CANTHER Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.; Medical Oncology Department, CHRU Lille, Lille, France.; Neuzillet C; Gastrointestinal Oncology, Medical Oncology Department, Curie Institute, Versailles St-Quentin-Paris Saclay University, Saint-Cloud, France.; Frigola J; Clinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Querol J; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Yáñez-Bartolomé M; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Castet F; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Fabregat-Franco C; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Escudero-Iriarte C; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Escorihuela M; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Arenas EJ; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Bernadó-Morales C; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Haro N; Neurosciences Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Giles FJ; Developmental Therapeutics Consortium, Chicago, Illinois.; Pozo ÓJ; Neurosciences Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Miquel JM; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Nuciforo PG; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Melé M; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain.; Serra V; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Arribas J; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Monforte de Lemos, Madrid, Spain.; Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Tabernero J; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Peiró S; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Macarulla T; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Tian TV; Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Shi Z; Department of Oncology Biomarker, Genentech Inc., South San Francisco, California.; Wulfkuhle J; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia.; Nowicka M; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Gallagher RI; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia.; Saura C; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Nuciforo PG; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Calvo I; Breast Cancer Unit, Centro Integral Oncologico Clara Campal (CIOCC), Madrid, Spain.; Andersen J; Medical Oncology/Hematology, Compass Oncology, Tigard, Oregon.; Passos-Coelho JL; Oncology Department, Hospital Beatriz Angelo, Loures, Portugal.; Gil-Gil MJ; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Medical Oncology Service, Institut Català d'Oncologia, L'Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.; Bermejo B; Hospital Clinico Universitario de Valencia, Valencia, Spain.; Pratt DA; Texas Oncology Cancer Center, US Oncology, Austin, Texas.; Ciruelos EM; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain.; Villagrasa P; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Wongchenko MJ; Department of Oncology Biomarker, Genentech Inc., South San Francisco, California.; Petricoin EF; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia.; Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Isakoff SJ; Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Wurm M; Boehringer Ingelheim RCV, GmbH & Co KG, Cancer Pharmacology and Disease Positioning, Vienna, Austria.; Schaaf O; Boehringer Ingelheim RCV, GmbH & Co KG, Drug Discovery Sciences, Vienna, Austria.; Reutner K; Boehringer Ingelheim RCV, GmbH & Co KG, Cancer Immunology and Immune Modulation, Vienna, Austria.; Ganesan R; Boehringer Ingelheim Pharmaceuticals, Inc., Biotherapeutics Discovery, Ridgefield, Conneticut.; Mostböck S; Boehringer Ingelheim RCV, GmbH & Co KG, Cancer Immunology and Immune Modulation, Vienna, Austria.; Pelster C; Boehringer Ingelheim RCV, GmbH & Co KG, Cancer Immunology and Immune Modulation, Vienna, Austria.; Böttcher J; Boehringer Ingelheim RCV, GmbH & Co KG, Drug Discovery Sciences, Vienna, Austria.; de Andrade Pereira B; Boehringer Ingelheim Pharma GmbH, Cancer Immunology and Immune Modulation, Biberach, Germany.; Taubert C; Allcyte GmbH, Vienna, Austria.; Alt I; Allcyte GmbH, Vienna, Austria.; Serna G; Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology, CIBERONC, Universitat Autonoma de Barcelona, Barcelona, Spain.; Auguste A; Boehringer Ingelheim Pharma GmbH & Co KG, Translational Medicine and Clinical Pharmacology, Biberach, Germany.; Stadermann KB; Boehringer Ingelheim Pharma GmbH & Co KG, Translational Medicine and Clinical Pharmacology, Biberach, Germany.; Delic D; Boehringer Ingelheim Pharma GmbH & Co KG, Translational Medicine and Clinical Pharmacology, Biberach, Germany.; Han F; Boehringer Ingelheim Pharmaceuticals, Inc., Biotherapeutics Discovery, Ridgefield, Conneticut.; Capdevila J; Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology, CIBERONC, Universitat Autonoma de Barcelona, Barcelona, Spain.; Nuciforo PG; Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology, CIBERONC, Universitat Autonoma de Barcelona, Barcelona, Spain.; Kroe-Barrett R; Boehringer Ingelheim Pharmaceuticals, Inc., Biotherapeutics Discovery, Ridgefield, Conneticut.; Adam PJ; Boehringer Ingelheim RCV, GmbH & Co KG, Cancer Immunology and Immune Modulation, Vienna, Austria.; Vogt AB; Boehringer Ingelheim RCV, GmbH & Co KG, Cancer Immunology and Immune Modulation, Vienna, Austria.; Hofmann I; Boehringer Ingelheim RCV, GmbH & Co KG, Cancer Immunology and Immune Modulation, Vienna, Austria. irmgard.hofmann@boehringer-ingelheim.com.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Editorial & Opinion
Nuciforo PG; Molecular Oncology Group Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Hergueta-Redondo M; Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ, Madrid, Spain.; Sarrio D; Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ, Madrid, Spain.; Molina-Crespo Á; Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ, Madrid, Spain.; Vicario R; Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.; Bernadó-Morales C; Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.; Martínez L; Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ, Madrid, Spain.; Rojo-Sebastián A; Pathology Department, MD Anderson Cancer Center, Madrid, Spain.; Serra-Musach J; Breast Cancer and Systems Biology Unit, ProCURE, Catalan Institute of Oncology, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.; Mota A; Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ, Madrid, Spain.; Translational Research Laboratory, MD Anderson Internacional Foundation, Madrid, Spain.; Martínez-Ramírez Á; Cytogenetics Department, MD Anderson Cancer Center, Madrid, Spain.; Castilla MÁ; Pathology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; González-Martin A; Oncology Department, MD Anderson Cancer Center, Madrid, Spain.; Pernas S; Breast Cancer and Systems Biology Unit, ProCURE, Catalan Institute of Oncology, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.; Cano A; Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ, Madrid, Spain.; Cortes J; Clinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autonoma de Barcelona, Barcelona, Spain.; Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Nuciforo PG; Molecular Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.; Peg V; Pathology Department, Hospital Vall d'Hebron University, Barcelona, Spain.; Palacios J; Pathology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Pujana MÁ; Breast Cancer and Systems Biology Unit, ProCURE, Catalan Institute of Oncology, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.; Arribas J; Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.; Clinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autonoma de Barcelona, Barcelona, Spain.; Molecular Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.; Moreno-Bueno G; Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ, Madrid, Spain.; Translational Research Laboratory, MD Anderson Internacional Foundation, Madrid, Spain.
Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Academic Journal
De Mattos-Arruda L; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.; Bottai G; Oncology Experimental Therapeutics Unit, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.; Nuciforo PG; Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Di Tommaso L; Division of Pathology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy, University of Milan, Milan, Italy.; Giovannetti E; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.; Cancer Pharmacology Laboratory, AIRC Start-Up Unit, University of Pisa, Pisa, Italy.; Peg V; Pathology Department, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.; Losurdo A; Division of Oncology and Hematology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.; Pérez-Garcia J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.; Masci G; Division of Oncology and Hematology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.; Corsi F; Deparment of Clinical and Biomedical Sciences 'Luigi Sacco', University of Milan, Milan, Italy.; Cortés J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.; Ramon y Cajal University Hospital, Madrid, Spain.; Seoane J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Calin GA; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Santarpia L; Oncology Experimental Therapeutics Unit, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.
Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Academic Journal
Nuciforo PG; Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain pnuciforo@vhio.net.; Aura C; Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain.; Holmes E; Frontier Science Scotland, Kincraig, UK.; Prudkin L; Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain.; Jimenez J; Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain.; Martinez P; Molecular Oncology Laboratory, Vall D'Hebron Institute of Oncology, Barcelona, Spain.; Ameels H; BrEAST Data Centre, Jules Bordet Institute, Brussels, Belgium.; de la Peña L; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Ellis C; GlaxoSmithKline, Collegeville, USA.; Eidtmann H; University Hospital Kiel, Kiel, Germany.; Piccart-Gebhart MJ; Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium.; Scaltriti M; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York.; Baselga J; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York Breast Medicine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Nuciforo PG
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어